{"result": "{\n    \"title\": \"Gilles De La Tourette Syndrome Treatment Community\",\n    \"summary\": \"This community is centered around the treatment of Gilles De La Tourette Syndrome, involving key entities such as Pergolide, Perphenazine, and Risperidone, which are used to palliate symptoms of the condition. Additionally, various side effects associated with these treatments, including chest pain and mental disorders, highlight the complexities of managing this syndrome.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant health implications and potential side effects associated with the treatments for Gilles De La Tourette Syndrome.\",\n    \"findings\": [\n        {\n            \"summary\": \"Key treatments for Gilles De La Tourette Syndrome\",\n            \"explanation\": \"Pergolide, Perphenazine, and Risperidone are the primary compounds used to palliate symptoms of Gilles De La Tourette Syndrome. Each of these medications has been specifically linked to the management of this condition, indicating their importance in therapeutic strategies. The relationships between these compounds and the syndrome underscore their critical role in treatment protocols. [Data: Entities (206, 205, 204); Relationships (504, 503, 502)]\"\n        },\n        {\n            \"summary\": \"Significant side effects of treatments\",\n            \"explanation\": \"The treatments for Gilles De La Tourette Syndrome are associated with various side effects, including chest pain, mental disorders, and anaemia. These side effects can complicate the management of the syndrome, necessitating careful monitoring and potential adjustments in treatment. The presence of these side effects highlights the need for healthcare providers to balance the benefits of symptom palliation with the risks of adverse effects. [Data: Entities (162, 209, 148); Relationships (449, 510, 514)]\"\n        },\n        {\n            \"summary\": \"Chest pain as a notable symptom\",\n            \"explanation\": \"Chest pain is a significant symptom that can arise from both the syndrome itself and as a side effect of the treatments. This dual association emphasizes the importance of thorough clinical evaluation when patients present with chest pain, as it may indicate underlying cardiovascular issues or complications from medication. The relationship between chest pain and treatments like Pergolide and Risperidone further complicates patient management. [Data: Entities (162); Relationships (452, 449)]\"\n        },\n        {\n            \"summary\": \"Mental health implications of treatment\",\n            \"explanation\": \"Mental disorders are a potential side effect of several compounds used in the treatment of Gilles De La Tourette Syndrome, including Pergolide, Perphenazine, and Risperidone. This association raises concerns about the psychological well-being of patients undergoing treatment, necessitating ongoing mental health assessments. The impact of these medications on mental health underscores the need for a holistic approach to treatment that considers both physical and psychological health. [Data: Entities (209); Relationships (508, 514)]\"\n        },\n        {\n            \"summary\": \"Breast disorder as a treatment-related concern\",\n            \"explanation\": \"Breast disorder is another potential side effect linked to the medications used for Gilles De La Tourette Syndrome. This highlights the importance of monitoring for breast health issues in patients receiving these treatments, particularly in women. The relationship between breast disorder and compounds like Pergolide and Risperidone indicates a need for healthcare providers to be vigilant about this aspect of patient care. [Data: Entities (148); Relationships (395, 398)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n206,PERGOLIDE,\"Pergolide is an ergot alkaloid used to palliate symptoms of Gilles De La Tourette Syndrome, with various side effects.\",11\n205,PERPHENAZINE,\"Perphenazine is a phenothiazine used to palliate symptoms of Gilles De La Tourette Syndrome, with various side effects.\",11\n204,RISPERIDONE,\"Risperidone is a compound used to palliate symptoms of Gilles De La Tourette Syndrome, with various side effects.\",11\n162,CHEST PAIN,\"Chest pain is a symptom that can indicate a range of conditions, from minor issues to serious heart problems. It is associated with various medical contexts, including being a side effect of Metformin, which may suggest potential cardiovascular issues. Additionally, chest pain can arise as a side effect of several compounds used to palliate Gilles De La Tourette Syndrome, reflecting discomfort in the chest area. Furthermore, it is also recognized as a symptom related to Sarcoma, again indicating discomfort in the chest region. Overall, chest pain serves as an important clinical sign that warrants further investigation to determine its underlying cause.\",5\n209,MENTAL DISORDER,\"Mental Disorder refers to a range of psychological effects that can arise as side effects from various compounds used in medical treatments. Specifically, it is associated with treatments for conditions such as Polycystic Ovary Syndrome and Gilles De La Tourette Syndrome, indicating that these compounds may impact psychological well-being. Additionally, the use of Isradipine has also been linked to the occurrence of mental disorders. This highlights the importance of monitoring psychological health when administering these treatments, as they may lead to significant psychological effects.\",5\n148,BREAST DISORDER,\"Breast Disorder refers to a range of issues related to breast health that can arise as a side effect from various compounds used in the treatment or palliation of different medical conditions. Specifically, it is associated with the management of Polycystic Ovary Syndrome, Gilles De La Tourette Syndrome, and Prostate Cancer. In the context of Polycystic Ovary Syndrome, Breast Disorder indicates potential complications affecting breast health. Similarly, in the treatment of Gilles De La Tourette Syndrome, it can impact breast tissue. Additionally, Breast Disorder may also occur as a side effect of compounds used to alleviate symptoms of Prostate Cancer. Overall, Breast Disorder is a significant concern linked to the pharmacological management of these diverse health conditions.\",4\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n504,GILLES DE LA TOURETTE SYNDROME,PERGOLIDE,Pergolide is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n503,GILLES DE LA TOURETTE SYNDROME,PERPHENAZINE,Perphenazine is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n502,GILLES DE LA TOURETTE SYNDROME,RISPERIDONE,Risperidone is used to palliate symptoms of Gilles De La Tourette Syndrome,37\n452,CHEST PAIN,SARCOMA,\"Chest pain is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",33\n368,ASTHENIA,PERGOLIDE,Asthenia is a potential side effect of Pergolide,24\n367,ASTHENIA,PERPHENAZINE,Asthenia is a potential side effect of Perphenazine,24\n366,ASTHENIA,RISPERIDONE,Asthenia is a potential side effect of Risperidone,24\n383,ANOREXIA,PERGOLIDE,Anorexia is a potential side effect of Pergolide,23\n382,ANOREXIA,PERPHENAZINE,Anorexia is a potential side effect of Perphenazine,23\n381,ANOREXIA,RISPERIDONE,Anorexia is a potential side effect of Risperidone,23\n106,ANAEMIA,PERGOLIDE,Anaemia is a potential side effect of Pergolide,22\n352,AGRANULOCYTOSIS,PERGOLIDE,Agranulocytosis is a potential side effect of Pergolide,22\n105,ANAEMIA,PERPHENAZINE,Anaemia is a potential side effect of Perphenazine,22\n351,AGRANULOCYTOSIS,PERPHENAZINE,Agranulocytosis is a potential side effect of Perphenazine,22\n104,ANAEMIA,RISPERIDONE,Anaemia is a potential side effect of Risperidone,22\n350,AGRANULOCYTOSIS,RISPERIDONE,Agranulocytosis is a potential side effect of Risperidone,22\n125,AMENORRHOEA,PERGOLIDE,Amenorrhoea is a potential side effect of Pergolide,21\n124,AMENORRHOEA,PERPHENAZINE,Amenorrhoea is a potential side effect of Perphenazine,21\n123,AMENORRHOEA,RISPERIDONE,Amenorrhoea is a potential side effect of Risperidone,21\n513,PERGOLIDE,HAEMOLYTIC ANAEMIA,Haemolytic anaemia is a potential side effect of Pergolide,18\n511,PERPHENAZINE,HAEMOLYTIC ANAEMIA,Haemolytic anaemia is a potential side effect of Perphenazine,18\n509,RISPERIDONE,HAEMOLYTIC ANAEMIA,Haemolytic anaemia is a potential side effect of Risperidone,18\n444,APLASTIC ANAEMIA,PERGOLIDE,Aplastic anaemia is a potential side effect of Pergolide,17\n443,APLASTIC ANAEMIA,PERPHENAZINE,Aplastic anaemia is a potential side effect of Perphenazine,17\n442,APLASTIC ANAEMIA,RISPERIDONE,Aplastic anaemia is a potential side effect of Risperidone,17\n448,CHEST PAIN,PIMOZIDE,Chest pain is a potential side effect of Pimozide,16\n449,CHEST PAIN,RISPERIDONE,Chest pain is a potential side effect of Risperidone,16\n450,CHEST PAIN,PERPHENAZINE,Chest pain is a potential side effect of Perphenazine,16\n451,CHEST PAIN,PERGOLIDE,Chest pain is a potential side effect of Pergolide,16\n508,PIMOZIDE,MENTAL DISORDER,Mental disorder is a potential side effect of Pimozide,16\n510,RISPERIDONE,MENTAL DISORDER,Mental disorder is a potential side effect of Risperidone,16\n512,PERPHENAZINE,MENTAL DISORDER,Mental disorder is a potential side effect of Perphenazine,16\n514,PERGOLIDE,MENTAL DISORDER,Mental disorder is a potential side effect of Pergolide,16\n395,BREAST DISORDER,PIMOZIDE,Breast disorder is a potential side effect of Pimozide,15\n396,BREAST DISORDER,RISPERIDONE,Breast disorder is a potential side effect of Risperidone,15\n397,BREAST DISORDER,PERPHENAZINE,Breast disorder is a potential side effect of Perphenazine,15\n398,BREAST DISORDER,PERGOLIDE,Breast disorder is a potential side effect of Pergolide,15\n518,MENTAL DISORDER,ISRADIPINE,\"Mental disorder is a side effect of Isradipine, indicating a direct relationship between the compound and the side effect.\",15\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}